Physician profile
Christopher Belyea
NPI 1447661822
$5,957.20
in general payments reported to CMS, 2019-2025
12 companies · $58.46 in 2025
The $58.46 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $960 · 2021: $31.39 · 2022: $3,709 · 2023: $213 · 2024: $217 · 2025: $58.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341 · Travel and Lodging: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.40 |
| Travel and Lodging | $146.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tricoast Surgical Solutions LLC | $2,625.98 | 2022-2025 | |
| Southtech Orthopedics | $1,200.00 | 2022 | |
| Supreme Orthopedic Systems, LLC | $960.00 | 2020 | |
| Stryker Corporation | $714.10 | 2019-2024 | Alphavent |
| Zimmer Biomet Holdings, INC. | $150.00 | 2019 | |
| Axogen | $108.96 | 2019 | |
| Exactech, INC. | $79.07 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $53.86 | 2024 | |
| Dynasplint Systems INC. | $20.34 | 2025 | Dynasplint |
| Endo Pharmaceuticals INC. | $20.13 | 2019 | |
| Integra Lifesciences Corporation | $19.20 | 2023 | Tenoglide |
| Skeletal Dynamics INC | $5.56 | 2023 | Ijs, Implate, Align |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Belyea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.